Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Terminated × Hemangioma, Capillary × Population Groups × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Hemangioma, Capillary 2 Premature Birth 1 Hemangioma 1

Interventions

Timolol 3 Population Groups 2 Imiquimod 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01147601 2017-07-05

Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas

Oregon Health and Science University

Phase EARLY_PHASE1 Terminated

6 enrolled 7 charts

Hemangioma, Hemangioma, Capillary

NCT01434849 2016-11-15

TiPPIH

The University of Texas Health Science Center at San Antonio

Phase 1 Terminated

Hemangioma, Capillary, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon ⚡